DUBLIN (AP) _ Avadel Pharmaceuticals PLC (AVDL) on Thursday reported a loss of $22.3 million in its fourth quarter.

On a per-share basis, the Dublin-based company said it had a loss of 38 cents.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.

For the year, the company reported a loss of $77.3 million, or $1.32 per share, swinging to a loss in the period.

Avadel shares have decreased 13% since the beginning of the year. The stock has dropped 28% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News